BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 11584986)

  • 1. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP; Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
    Kurz A; Schwalen S S; Schmitt A
    Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
    Stoppe G; Schreiner A; Schmitt AB
    Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.